Roche revises sales expectations upwards on uptake of biologics
Despite increased competition from biosimilars in Europe, Roche announces sales of its pharmaceutical divisions are up by 10%.
Archives for April 17, 2019
Alvotech provides Stelara biosimilar supply to Fuji Pharma
Fuji Pharma signs agreement to receive an exclusive supply of the ustekinumab biosimilar for the Japanese market, furthering a previous investment agreement.
Kiadis gains NK-cell technology for immunology therapies through CytoSen acquisition
Kiadis Pharma acquires CytoSen Therapeutics and gains NK-cell technology capabilities to complement its own T-cell platform.